Best CGM for Non-Diabetics (2026): Stelo vs Lingo, No Rx
Not medical advice. This compares the two over-the-counter glucose biosensors on their FDA records, sensor life and price, and summarizes what CGM studies in people without diabetes show. If you have diabetes, use insulin, or have had hypoglycemia, these products exclude you by design; talk to your clinician about a prescription monitor.
Quick answer
Only two glucose monitors are sold without a prescription, both are FDA-cleared, and the choice is sensor life against price. Dexcom’s Stelo (K262472) wears for 15 days and costs $3.30 a day in the 2-pack; Abbott’s Lingo (K233655) wears for 14 days and costs $3.04 a day in the 4-pack, $3.15 as a single. In 153 healthy adults on blinded sensors, glucose sat between 70 and 140 mg/dL 96% of the time and above 140 for about 30 minutes a day.
Buy Stelo if you want the longer sensor and the mature app; buy one Lingo if you want to try the idea for two weeks. Treat it as a 14-to-30-day experiment: the pooled trials show a glucose benefit in prediabetes, none in people already normal, and no weight change. See the comparison →
What a normal glucose trace looks like
The reason to read this before buying a sensor is that the app will show you spikes, and you need to know which ones are normal. The reference dataset is a multicenter study that put blinded Dexcom sensors on 153 healthy, non-obese, non-diabetic people aged 7 to 80 for up to 10 days. Mean glucose was 98 to 99 mg/dL in every age group except the over-60s (104), the median person spent 96% of the time between 70 and 140 mg/dL, exceeded 140 for a median 2.1% of the day (about 30 minutes), dipped below 70 for 1.1% (about 15 minutes), and had a within-person variability of 17% (Shah 2019, PMID 31127824). A post-meal rise above 140 that comes back down within an hour or two is what healthy looks like; the numbers the consumer apps color amber are, in this dataset, half an hour of an ordinary day.
| Item | Value (%) |
|---|---|
| 70-140 mg/dL | 96% |
| Above 140 mg/dL | 2.1% |
| Below 70 mg/dL | 1.1% |
Does wearing one help if you do not have diabetes?
That is the question the sales copy answers and the literature answers more narrowly. A 2026 systematic review pooled every study of CGM in people without diabetes it could find, 23 of them (7 randomized), covering 1,074 people in 11 countries, most of them lifestyle programs that used the sensor as feedback. Mean glucose improved against controls (standardized mean difference -0.54, P = 0.03); body-mass index did not (P = 0.19); adherence to the programs was higher; and the glucose benefit was concentrated in people with prediabetes, with no appreciable benefit in people whose glucose was already normal. The authors’ conclusion is that a CGM works as a biofeedback tool inside a structured program and is unlikely to manage weight on its own (Liao 2026, PMID 41588451). What a sensor reliably provides is a personal answer to a specific question: what does this meal, this walk, this night’s sleep do to my glucose. That is worth a few weeks and $91. It is not a demonstrated way to lose weight, and both makers’ own labelling markets it as information, not treatment. Pair it with the berberine evidence if that is why you are here, and with a fasting glucose or HbA1c from a lab if the sensor shows you something you did not expect.
The FDA record: both are cleared, and that is the whole category
VerificationopenFDA 510(k) database, queried 2026-09-19: 4 record(s) for Stelo (latest 2026-08-11, K262472, “Stelo Glucose Biosensor System”, product code SBH); 1 record(s) for Lingo (2024-05-29, K233655, “Lingo Glucose System”, product code SAF).
Over-the-counter glucose biosensors are a new FDA category, and as of 2026-09-19 it contains these two. Both are cleared for adults who do not use insulin, both use the makers’ prescription sensor hardware, and both explicitly exclude people who need hypoglycemia alarms. On accuracy, Abbott’s current 15-day Libre sensors, the family Lingo is drawn from, reported a mean absolute relative difference of 8.2% against a laboratory reference in 149 adults, with 94.2% of readings within 20% of the reference (Alva 2026, PMID 40183340). Stelo is built on Dexcom’s prescription-sensor platform and its performance figures are in the clearance summary for K262472. Anything else sold as a “CGM for non-diabetics” is either one of these two under a subscription brand or a prescription device being resold.
Stelo vs Lingo, by cost per day of wear
Sensor life times sensors in the pack is the number that matters; the pack price divided by it is what you pay per day on your arm. Prices are current Amazon prices.
| Product | Buy | Per day of wear | Sensor life | Days per pack | Price | Per 30 days | 510(k) |
|---|---|---|---|---|---|---|---|
| Lingo Continuous Glucose Monitor, 4 biosensors | Check price | $3.04 | 14 days | 56 | $169.99 | $91 | K233655 |
| Lingo Continuous Glucose Monitor, 1 biosensor | Check price | $3.15 | 14 days | 14 | $44.10 | $95 | K233655 |
| Lingo Continuous Glucose Monitor, 2 biosensors | Check price | $3.15 | 14 days | 28 | $88.20 | $95 | K233655 |
| Stelo Glucose Biosensor, 2-pack | Check price | $3.30 | 15 days | 30 | $98.88 | $99 | K262472 |
| Stelo Glucose Biosensor, 1-pack | Check price | $3.96 | 15 days | 15 | $59.40 | $119 | K262472 |
The spread is $3.04 to $3.96 a day, a 1.30× range that is mostly pack size: the single Lingo costs 1.04× the 4-pack per day. Continuous wear runs $91 to $119 a month, which is why the honest recommendation is an experiment of a sensor or two rather than a habit.
Which CGM to buy
Product links go to Amazon and we may earn a commission if you buy. It never changes which product we pick or what we say about it. How we choose.
Frequently asked questions
Which CGM is best for non-diabetics?
There are two over-the-counter choices and both have an FDA 510(k) on file: Dexcom's Stelo (K262472, a 15-day sensor) and Abbott's Lingo (K233655, a 14-day sensor). Per day of wear they cost $3.30 (Stelo 2-pack) and $3.04 (Lingo 4-pack) to $3.15 (Lingo single). Stelo is the one with the longer sensor and a mature app inherited from Dexcom's prescription monitors; Lingo is cheaper to try for two weeks. Neither is for people on insulin.
What should my glucose be if I do not have diabetes?
A multicenter study put blinded CGMs on 153 healthy, non-obese, non-diabetic people aged 7 to 80: mean glucose was 98 to 99 mg/dL, a median 96% of the time was spent between 70 and 140 mg/dL, glucose exceeded 140 mg/dL for a median 2.1% of the day (about 30 minutes) and dipped under 70 for 1.1%. That is the reference: brief excursions above 140 after meals are normal, and a trace that never leaves 70 to 140 is not the target, it is the average.
Does wearing a CGM improve your health if you are not diabetic?
It depends on where you start. A 2026 systematic review pooled 23 studies (7 randomized trials) in 1,074 non-diabetic people across 11 countries, mostly lifestyle programs using the sensor as feedback: mean glucose improved against controls (standardized mean difference -0.54, P = 0.03), body-mass index did not (P = 0.19), adherence to the program was higher, and the glucose benefit was in people with prediabetes, with no appreciable benefit in people whose glucose was already normal. The review's conclusion is that a CGM is a biofeedback tool inside a structured program, not a weight-loss device on its own. The honest use for a healthy person is a two-to-four-week experiment, not a subscription.
How accurate are over-the-counter CGMs?
Both are built on the makers' prescription sensor platforms. Lingo itself has no published accuracy paper we could find; Abbott's current 15-day Libre sensors, the family it comes from, reported a mean absolute relative difference of 8.2% against a laboratory reference in 149 adults, with 94.2% of readings within 20% of the reference. Dexcom's Stelo is cleared on the G7 platform; its performance data are in its FDA clearance summary. For a non-diabetic tracking meal responses, that accuracy is more than enough; it is not a substitute for a diagnostic blood test, and interstitial glucose lags blood by several minutes.
Is Stelo or Lingo cheaper?
Per day of wear, Lingo Continuous Glucose Monitor, 4 biosensors is cheapest at $3.04 a day ($91.07 a month) and Stelo Glucose Biosensor, 1-pack dearest at $3.96. The Stelo 2-pack ($98.88 for 30 days) and the Lingo 4-pack ($169.99 for 56 days) are the value packs; the single Lingo ($44.10) is the cheapest way to try the whole idea for 14 days. Both are HSA/FSA eligible.
Who should not use an over-the-counter CGM?
Both makers exclude people on insulin, people on dialysis and anyone with problematic hypoglycemia, and Stelo's Amazon listing adds anyone with a history of an eating disorder or who would change medication without a clinician. The alerts are not the urgent low-glucose alarms of the prescription devices. If you have diabetes, a prescription CGM with alarms is the right product and is often covered.
Related guides
- At-home tests and monitors: which ones a lab actually runs
- Berberine for blood sugar: the trials
- Berberine vs metformin
- GLP-1 users: nutrition and supplements
- Chromium and blood sugar
Sources
- Shah VN, et al. “Continuous Glucose Monitoring Profiles in Healthy Nondiabetic Participants: A Multicenter Prospective Study.” J Clin Endocrinol Metab. 2019. PMID: 31127824
- Liao X, et al. “Continuous glucose monitoring in non-diabetic populations: a systematic review of observational and interventional studies with meta-analysis.” Eur J Med Res. 2026. PMID: 41588451
- Alva S, et al. “Accuracy of a 15-day Factory-Calibrated Continuous Glucose Monitoring System With Improved Sensor Design.” J Diabetes Sci Technol. 2026. PMID: 40183340
- US FDA. 510(k) premarket notification database (openFDA): K262472 Stelo Glucose Biosensor System; K233655 Lingo Glucose System. Queried 2026-09-19. open.fda.gov